Baillie Gifford & Co
MYGN icon

Baillie Gifford & Co’s Myriad Genetics MYGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,970,006
Closed -$128M 247
2020
Q1
$128M Buy
8,970,006
+4,828
+0.1% +$69.1K 0.14% 92
2019
Q4
$244M Sell
8,965,178
-278,625
-3% -$7.59M 0.24% 83
2019
Q3
$265M Sell
9,243,803
-283,339
-3% -$8.11M 0.3% 74
2019
Q2
$265M Sell
9,527,142
-13,444
-0.1% -$373K 0.28% 75
2019
Q1
$317M Buy
9,540,586
+55,642
+0.6% +$1.85M 0.35% 67
2018
Q4
$276M Sell
9,484,944
-62,249
-0.7% -$1.81M 0.36% 64
2018
Q3
$439M Buy
9,547,193
+92,008
+1% +$4.23M 0.47% 53
2018
Q2
$353M Sell
9,455,185
-107,778
-1% -$4.03M 0.38% 56
2018
Q1
$283M Sell
9,562,963
-62,883
-0.7% -$1.86M 0.33% 60
2017
Q4
$331M Buy
9,625,846
+15,309
+0.2% +$526K 0.41% 57
2017
Q3
$348M Sell
9,610,537
-54,710
-0.6% -$1.98M 0.44% 52
2017
Q2
$250M Sell
9,665,247
-257,206
-3% -$6.65M 0.34% 62
2017
Q1
$191M Sell
9,922,453
-237,305
-2% -$4.56M 0.28% 72
2016
Q4
$169M Sell
10,159,758
-290,064
-3% -$4.84M 0.28% 69
2016
Q3
$215M Sell
10,449,822
-871,476
-8% -$17.9M 0.34% 62
2016
Q2
$346M Sell
11,321,298
-45,738
-0.4% -$1.4M 0.62% 44
2016
Q1
$425M Buy
11,367,036
+50,708
+0.4% +$1.9M 0.75% 34
2015
Q4
$488M Buy
11,316,328
+629,570
+6% +$27.2M 0.85% 32
2015
Q3
$401M Buy
10,686,758
+311,000
+3% +$11.7M 0.78% 38
2015
Q2
$353M Buy
10,375,758
+448,399
+5% +$15.2M 0.63% 43
2015
Q1
$351M Buy
9,927,359
+268,356
+3% +$9.5M 0.67% 43
2014
Q4
$329M Buy
9,659,003
+675,100
+8% +$23M 0.66% 44
2014
Q3
$347M Buy
8,983,903
+198,400
+2% +$7.65M 0.76% 38
2014
Q2
$342M Buy
8,785,503
+118,400
+1% +$4.61M 0.74% 37
2014
Q1
$296M Buy
8,667,103
+4,118,403
+91% +$141M 0.7% 44
2013
Q4
$95.4M Buy
4,548,700
+885,300
+24% +$18.6M 0.23% 73
2013
Q3
$86.1M Buy
+3,663,400
New +$86.1M 0.22% 75